Srishti Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-05-2024
- Paid Up Capital ₹ 0.10 M
as on 20-05-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Srishti Lifescience
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dineshkumar Panchasara, Prateekkumar Patel, and Vicky Peshvani serve as directors at the Company.
- CIN/LLPIN
U15400GJ2020PTC115693
- Company No.
115693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Srishti Lifescience Private Limited offer?
Srishti Lifescience Private Limited offers a wide range of products and services, including Plant Extracts, Tulsi Extracts, Nutraceuticals, Allopathic Immunity Booster.
Who are the key members and board of directors at Srishti Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prateekkumar Patel  | Managing Director | 21-Aug-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vicky Peshvani | Director | 28-Nov-2021 | Current |
| Dineshkumar Panchasara | Director | 21-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Srishti Lifescience.
Enhance accessibility to Srishti Lifescience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Srishti Lifescience?
Unlock access to Srishti Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
6 years 28 days Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Srishti Lifescience?
Srishti Lifescience has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srishti Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srishti Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.